Overview
Alexandria
Alexandria Real Estate Equities owns, develops, and operates offices and labs to life science tenants including biotech and pharmaceutical companies, universities, research institutions, medical office developers, and government agencies. A real estate investment trust (REIT), Alexandria owns approximately 410 specialized properties with approximately 47.2 million sq. ft. of rentable space in the US and Canada. Its portfolio is largely located in
...
Read More high-tech hotbeds such as Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The company was founded in 1994.
Read Less
Read More high-tech hotbeds such as Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The company was founded in 1994.
Read Less
#
958
Fortune 1000 Revenue Rank
Peter M Moglia
See more contacts
Lessors of Real Estate
,
Real Estate
,
Real Estate and Rental and Leasing
,
Real estate investment trusts
Activities Related to Real Estate
,
Automotive Equipment Rental and Leasing
,
Commercial and Industrial Machinery and Equipment Rental and Leasing
,
Consumer Goods Rental
,
General Rental Centers
,
Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)
,
Offices of Real Estate Agents and Brokers
?
?
?
Actual
?
Actual
$3.12 billion
Actual
7.29%
211.61%
$37,527
DEC
?
?
NYSE:ARE
Contacts
Get in Touch with 5 Principals* and 336 Contacts
-
Peter M MogliaChief Executive Officer and Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$3.12 billion
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
Cash Flow (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Net Operating Cash | $1,505 | $1,631 | $1,294 |
Net Investing Cash | -$1,511 | -$2,501 | -$5,080 |
Net Financing Cash | -$93 | $674 | $4,230 |
Net Change in Cash | -$99 | -$196 | $444 |
Cash at Beginning of Period | $661 | $858 | $415 |
Cash at End of Period | $560 | $661 | $858 |
Capital Expenditure | $ | $ | $ |
Assets (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Assets | |||
Cash and Cash Equivalents | $552 | $618 | $825 |
Accounts Receivable | $6 | $8 | $8 |
Inventories | $ | $ | $ |
Other Current Assets | $225 | $155 | $141 |
Asset Summary | |||
Total Current Assets | $784 | $782 | $974 |
Tangible Fixed Assets | $1,250 | $1,149 | $1,346 |
Intangible Assets | $ | $ | $ |
Total Assets | $37,527 | $36,771 | $35,523 |
Liabilities (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Liabilities | |||
Accounts Payable | $535 | $524 | $390 |
Short-Term Debt | $ | $100 | $ |
Other Current Liabilities | $1,423 | $1,377 | $1,283 |
Liability Summary | |||
Total Current Liabilities | $1,958 | $2,001 | $1,673 |
Long-Term Debt | $12,244 | $11,216 | $10,160 |
Other Long-Term Liabilities | $354 | $480 | $530 |
Total Liabilities | $15,129 | $14,148 | $12,840 |
Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Equity | |||
Common Stock | $2 | $2 | $2 |
Retained Earnings | $ | $ | $ |
Equity Summary | |||
Total Equity | $17,889 | $18,471 | $18,972 |
Shares Outstanding | 172,203,443 | 171,910,599 | 170,748,395 |